A detailed history of Cypress Advisory Group LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Cypress Advisory Group LLC holds 5,526 shares of WST stock, worth $1.33 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
5,526
Previous 3,485 58.57%
Holding current value
$1.33 Million
Previous $780 Million 54.97%
% of portfolio
0.94%
Previous 0.71%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$190.39 - $227.7 $388,585 - $464,735
2,041 Added 58.57%
5,526 $1.21 Billion
Q1 2025

Apr 17, 2025

BUY
$199.11 - $347.87 $693,898 - $1.21 Million
3,485 New
3,485 $780 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $17.8B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Cypress Advisory Group LLC Portfolio

Follow Cypress Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Advisory Group LLC with notifications on news.